VEGFA, VEGFR1, VEGFR2 serum and cerebrospinal fluid concentration in patients with acute leukemia
Background. Vascular endothelial growth factor A (VEGFA) is one of the most important factors for regulation of hematopoietic stem cells differentiation. It is involved in leukemogenesis and central nervous system (CNS) damage in acute leukemia. According to the literature, the VEGFA production by b...
Saved in:
| Main Authors: | E. I. Zakharko, V. N. Dvirnyk, Yu. A. Chabaeva, D. G. Drokova, E. B. Rybkina, K. A. Lavrishinets, A. V. Bulgakov, M. N. Panasenko, Z. T. Fidarova, I. A. Lukianova, O. A. Aleshina, S. M. Kulikov, T. V. Gaponova, V. V. Troitskaya, E. N. Parovichnikova |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
ABV-press
2024-04-01
|
| Series: | Онкогематология |
| Subjects: | |
| Online Access: | https://oncohematology.abvpress.ru/ongm/article/view/912 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Changes in VEGFR1 and VEGFR2 expression and endothelial cell maturity in laboratory animals with a model of Alzheimer’s disease
by: M. V. Kukla, et al.
Published: (2025-01-01) -
Cinobufagin inhibits hepatocellular carcinoma EMT-like stemness via VEGF/VEGFR2 autocrine signaling
by: Mingjun Ye, et al.
Published: (2025-05-01) -
VEGFR2 but not VEGFR3 governs integrity and remodeling of thyroid angiofollicular unit in normal state and during goitrogenesis
by: Jeon Yeob Jang, et al.
Published: (2017-04-01) -
Targeting NGF but not VEGFR1 or BDNF signaling reduces endometriosis-associated pain in mice
by: Tiago H. Zaninelli, et al.
Published: (2025-07-01) -
Design, synthesis, and antiproliferative activity of new 5-ethylsulfonyl-indazole-3-carbohydrazides as dual EGFR/VEGFR-2 kinases inhibitors
by: Lamya H. Al-Wahaibi, et al.
Published: (2025-12-01)